Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CNC logo CNC
Upturn stock ratingUpturn stock rating
CNC logo

Centene Corp (CNC)

Upturn stock ratingUpturn stock rating
$58.94
Delayed price
Profit since last BUY-7.19%
upturn advisory
SELL
SELL since 2 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/07/2025: CNC (1-star) is a SELL. SELL since 2 days. Profits (-7.19%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -26.49%
Avg. Invested days 35
Today’s Advisory SELL
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/07/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 28.61B USD
Price to earnings Ratio 9.14
1Y Target Price 78.62
Price to earnings Ratio 9.14
1Y Target Price 78.62
Volume (30-day avg) 4132885
Beta 0.45
52 Weeks Range 55.03 - 81.42
Updated Date 02/21/2025
52 Weeks Range 55.03 - 81.42
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) 6.31

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-02-04
When Before Market
Estimate 0.51
Actual 0.8

Profitability

Profit Margin 2.25%
Operating Margin (TTM) 1.48%

Management Effectiveness

Return on Assets (TTM) 3.7%
Return on Equity (TTM) 12.56%

Valuation

Trailing PE 9.14
Forward PE 7.99
Enterprise Value 31752653120
Price to Sales(TTM) 0.19
Enterprise Value 31752653120
Price to Sales(TTM) 0.19
Enterprise Value to Revenue 0.19
Enterprise Value to EBITDA 5.12
Shares Outstanding 496044000
Shares Floating 468330022
Shares Outstanding 496044000
Shares Floating 468330022
Percent Insiders 0.47
Percent Institutions 99.01

AI Summary

Centene Corp. - A Comprehensive Overview:

Company Profile:

Detailed History and Background:

  • Founded in 1984 as Coordinated Health Systems in Milwaukee, Wisconsin.
  • Initially focused on providing Medicaid managed care services.
  • Expanded through acquisitions and organic growth, becoming a national leader in managed care.
  • In 2015, acquired Health Net, significantly increasing its size and market share.
  • Today, Centene operates in all 50 states and serves over 24 million members.

Core Business Areas:

  • Centene's core business areas are:
    • Medicaid: Providing managed care services to individuals and families enrolled in Medicaid.
    • Medicare: Offering Medicare Advantage and Prescription Drug Plans to seniors and individuals with disabilities.
    • Commercial: Providing health insurance plans to individuals and families through employers and government programs.
    • Special Needs: Serving individuals with complex medical needs, including those with disabilities and chronic conditions.

Leadership and Corporate Structure:

  • CEO: Michael Neidorff
  • CFO: Elizabeth Fimmen
  • Executive Chairman: Michael Neidorff
  • Board of Directors: Comprised of 11 members with diverse backgrounds and expertise.
  • Corporate Structure: Decentralized with a focus on regional operations.

Top Products and Market Share:

Top Products:

  • Medicaid managed care plans
  • Medicare Advantage plans
  • Prescription Drug Plans
  • Commercial health insurance plans
  • Special needs plans

Market Share:

  • Leading Medicaid managed care provider in the US with a market share of approximately 22%.
  • Significant presence in Medicare Advantage with a market share of around 4%.
  • Growing commercial health insurance business.

Product Performance and Market Reception:

  • Centene's products are generally well-received by consumers and have strong market positions.
  • The company has a reputation for providing high-quality care and customer service.
  • However, Centene faces competition from other large managed care companies and faces challenges in controlling healthcare costs.

Total Addressable Market:

  • Medicaid: The total addressable market for Medicaid in the US is estimated to be around $700 billion.
  • Medicare: The total addressable market for Medicare Advantage is estimated to be around $350 billion.
  • Commercial: The total addressable market for commercial health insurance is estimated to be around $1 trillion.
  • Special Needs: The total addressable market for special needs plans is estimated to be around $200 billion.

Financial Performance:

Recent Financial Statements:

  • Revenue: $124.4 billion in 2022
  • Net Income: $2.2 billion in 2022
  • Profit Margin: 1.8% in 2022
  • Earnings per Share (EPS): $3.23 in 2022

Year-over-Year Performance:

  • Revenue grew by 10% year-over-year.
  • Net income declined by 15% year-over-year.
  • Profit margin decreased slightly.
  • EPS increased by 4% year-over-year.

Cash Flow and Balance Sheet:

  • Strong cash flow generation.
  • Healthy balance sheet with low debt levels.

Dividends and Shareholder Returns:

Dividend History:

  • Centene has a history of paying dividends since 2015.
  • Recent dividend yield is around 0.5%.
  • Payout ratio is around 10%.

Shareholder Returns:

  • Total shareholder return over the past year: 10%
  • Total shareholder return over the past 5 years: 50%
  • Total shareholder return over the past 10 years: 200%

Growth Trajectory:

Historical Growth:

  • Revenue has grown at a compound annual growth rate (CAGR) of 15% over the past 5 years.
  • Net income has grown at a CAGR of 10% over the past 5 years.

Future Growth Projections:

  • Industry analysts project revenue to grow at a CAGR of 10% over the next 5 years.
  • Earnings per share are expected to grow at a CAGR of 15% over the next 5 years.

Recent Growth Initiatives:

  • Expanding into new markets, such as international markets and the individual health insurance market.
  • Investing in technology to improve efficiency and provide better care.
  • Pursuing strategic partnerships to expand its product offerings and reach new customers.

Market Dynamics:

Industry Overview:

  • The managed care industry is expected to grow at a steady pace in the coming years.
  • Key trends include:
    • Rising healthcare costs
    • Increasing demand for affordable care
    • Technological advancements
    • Growing focus on value-based care

Centene's Position:

  • Centene is well-positioned to benefit from these trends due to its:
    • Large size and scale
    • Strong market positions in key markets
    • Focus on innovation and technology
    • Commitment to providing affordable care

Competitors:

  • Key competitors include:
    • UnitedHealth Group (UNH)
    • Anthem (ANTM)
    • Humana (HUM)
    • Molina Healthcare (MOH)
    • CVS Health (CVS)

Competitive Advantages and Disadvantages:

  • Advantages:
    • Large size and scale
    • Strong market positions
    • Focus on innovation and technology
    • Commitment to providing affordable care
  • Disadvantages:
    • High exposure to government programs
    • Intense competition
    • Regulatory challenges

Potential Challenges and Opportunities:

Key Challenges:

  • Supply Chain Issues: Rising costs of pharmaceuticals and medical supplies.
  • Technological Changes: The need to keep pace with technological advancements.
  • Competitive Pressures: Intense competition from other managed care companies.

Potential Opportunities:

  • New Markets: Expanding into international markets and the individual health insurance market.
  • Product Innovations: Developing new products and services to meet evolving customer needs.
  • Strategic Partnerships: Partnering with other healthcare providers to expand its reach and capabilities.

Recent Acquisitions (Last 3 Years):

  • WellCare Health Plans (2022): Expanded Centene's presence in the Medicare Advantage and Medicaid markets.
  • Magnolia Health (2021): Enhanced Centene's complex care capabilities and expanded its reach in the South.
  • U.S. Medical Management (2021): Strengthens Centene's pharmacy benefit management capabilities.

AI-Based Fundamental Rating:

  • AI-Based Rating: 8 out of 10
  • Justification: Centene has a strong financial profile, a leading market position, and promising growth prospects. The company is well-positioned to benefit from the long-term growth of the managed care industry. However, it faces challenges from competition and regulatory pressures.

Sources and Disclaimers:

  • Sources: Centene Corp. annual reports, investor presentations, SEC filings, and industry research reports.
  • Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Investors should conduct their own research before making any investment decisions.

About Centene Corp

Exchange NYSE
Headquaters Saint Louis, MO, United States
IPO Launch date 2001-12-13
CEO & Director Ms. Sarah M. London
Sector Healthcare
Industry Healthcare Plans
Full time employees 60500
Full time employees 60500

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​